Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. 

₺183.60
22
-₺12.80-6.52% 11:44 Today

Statistics

Day High
193.1
Day Low
180.3
52W High
380
52W Low
111.6
Volume
1,101,866
Avg. Volume
523,586
Mkt Cap
4.38B
P/E Ratio
67.49
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Nov 23
₺0.41
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Financials

7.11%Profit Margin
Profitable
2022
2023
2024
2025
709.08MRevenue
50.39MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ONCSM.IS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap129.55B
Intuitive Surgical, Inc. designs, manufactures, and markets robotic products for minimally invasive surgery, competing in the broader oncology treatment market by offering alternative cancer surgery solutions.
Medtronic
MDT
Mkt Cap120.46B
Medtronic plc offers medical technologies, including robotic-assisted surgery systems, that serve the oncology sector, providing competitive alternatives to traditional cancer treatment methods.
Boston Scientific
BSX
Mkt Cap69.27B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, including oncology, competing in the medical device market for cancer treatment.
Zimmer Biomet
ZBH
Mkt Cap18.71B
Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare services and products, some of which are used in oncology, indirectly competing in the cancer care market.
Stryker
SYK
Mkt Cap116.27B
Stryker Corporation specializes in medical technologies, including surgical equipment and neurotechnology products that can be used in cancer treatments, competing in the medical technology market relevant to oncology.
Globus Medical
GMED
Mkt Cap10.51B
Globus Medical, Inc. focuses on musculoskeletal solutions, including products for spine disorders which may overlap with cancer treatments, indirectly competing in the oncology market.
Abbvie
ABBV
Mkt Cap453.19B
AbbVie Inc. researches and develops pharmaceutical products, including those for cancer treatment, competing in the pharmaceutical and biotech sector against Oncosem's oncology solutions.

About

Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi manufactures and sells chemotherapy drug preparation kits and equipment in Turkey. The company offers OncoCare Monolitik, an automated chemotherapy drug preparation device; OncoCare Plus, a chemotherapy drug guide; OncoWaste and M-Waste, a hazardous waste sealing system, chemotherapy drugs, cephalosporins, penicillins, infectious waste and toxic laboratory waste; OncoCare Set, a chemotherapy preparation and administration consumables; and Oncocare Infusion Pump. It also provides Oncosem components, such as pinch clamps, roller clamps, 3/4 way connectors, vial adapters, drip chambers, hydrophobic caps, male and rotating luer locks, spikes, taxol filters, check valves, and covers. The company was incorporated in 2008 and is headquartered in Ankara, Turkey.
Show more...
CEO
Mr. Erol Celik
Employees
420
Country
Turkey
ISIN
TREONCO00026

Listings

0 Comments

Share your thoughts

FAQ

What is Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. stock price today?
The current price of ONCSM.IS is ₺183.60 TRY — it has decreased by -6.52% in the past 24 hours. Watch Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. stock price performance more closely on the chart.
What is Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Istanbul Stock Exchange exchange Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. stocks are traded under the ticker ONCSM.IS.
Is Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. stock price growing?
ONCSM.IS stock has fallen by -18.04% compared to the previous week, the month change is a -24.04% fall, over the last year Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. has showed a +47.71% increase.
What is Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. market cap?
Today Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. has the market capitalization of 4.38B
What is Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. revenue for the last year?
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. revenue for the last year amounts to 709.08M TRY.
What is Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. net income for the last year?
ONCSM.IS net income for the last year is 50.39M TRY.
Does Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. pay dividends?
Yes, ONCSM.IS dividends are paid annual. The last dividend per share was 0.41 TRY. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. have?
As of September 07, 2026, the company has 420 employees.
In which sector is Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. located?
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. operates in the Health & Wellness sector.
When did Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. complete a stock split?
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. has not had any recent stock splits.
Where is Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. headquartered?
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. is headquartered in Ankara, Turkey.